Deletions in MAP3K7 have recently been associated with early PSA recurrence, and in tumours that do not contain the TMPRSS2-ERG gene fusion, a tumour-suppressor role for MAP3K7 has been proposed (Kluth et al., 2013). Here, TMPRSS2 is linked to neoplasm.